Mark A. Feitelson
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 86
- Hepatitis B Virus Studies 83
- Liver Disease Diagnosis and Treatment 31
- Hepatology 48
- Hepatitis C virus research 43
- Co-authors
- Alla Arzumanyan (14 shared papers)Helena Reis (3 shared papers)Enrique A. Mesri (1 shared paper)Karl Münger (1 shared paper)Zhaorui Lian (18 shared papers)Jingbo Pan (11 shared papers)Marcia M. Clayton (17 shared papers)Bill Sun (13 shared papers)
- Journals
- Hepatology (9 papers)Journal of Virology (8 papers)Oncogene (5 papers)Proceedings of the National Academy of Sciences (4 papers)Virology (4 papers)
- Partner nations
- United StatesChinaSouth Africa
In The Last Decade
Mark A. Feitelson
124 papers receiving 6.0k citations
Mark A. Feitelson's Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 1.9k
- Epidemiology 3.2k
- Cancer Research 980
- Oncology 1.4k
- Molecular Biology 2.3k
Countries citing papers authored by Mark A. Feitelson
This map shows the geographic impact of Mark A. Feitelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Feitelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Feitelson more than expected).
Fields of papers citing papers by Mark A. Feitelson
This network shows the impact of papers produced by Mark A. Feitelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Feitelson. The network helps show where Mark A. Feitelson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Feitelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Hit paper breakdown → | 2013 | 647 |
| 2 | Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Hit paper breakdown → | 1994 | 563 |
| 3 | Human Viral Oncogenesis: A Cancer Hallmarks Analysis Hit paper breakdown → | 2014 | 478 |
| 4 | 1995 | 299 | |
| 5 | 2002 | 258 | |
| 6 | Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. | 1997 | 195 |
| 7 | 1990 | 193 | |
| 8 | 2006 | 181 | |
| 9 | 2013 | 122 | |
| 10 | Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. | 1991 | 105 |
| 11 | 2013 | 100 | |
| 12 | 2011 | 96 | |
| 13 | 2011 | 93 | |
| 14 | 1991 | 91 | |
| 15 | 2005 | 88 | |
| 16 | 1999 | 85 | |
| 17 | 2012 | 83 | |
| 18 | 2001 | 81 | |
| 19 | 2023 | 78 | |
| 20 | 1992 | 68 |
About Mark A. Feitelson
Mark A. Feitelson is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and Oncology, having authored 124 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (83 papers), Hepatitis C virus research (43 papers), Liver Disease Diagnosis and Treatment (31 papers), Cancer-related Molecular Pathways (12 papers), NF-κB Signaling Pathways (12 papers), Animal Virus Infections Studies (10 papers), Ubiquitin and proteasome pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (3.2k citations), Cancer Research (980 citations), Oncology (1.4k citations) and Molecular Biology (2.3k citations). Mark A. Feitelson has collaborated with scholars based in United States, China and South Africa. Frequent co-authors include Alla Arzumanyan, Helena Reis, Enrique A. Mesri, Karl Münger, Zhaorui Lian, Jingbo Pan, Marcia M. Clayton, Bill Sun, Lifeng Duan and Heidi Yeh. Their work appears in journals such as Hepatology, Journal of Virology, Oncogene, Proceedings of the National Academy of Sciences and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.